- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 148
AbCellera accelerates with $105m
University of Minnesota has invested in UBC spinout AbCellera's series B round that also included Eli Lilly.
May 28, 2020MGI Tech completes $1bn series B sequence
A year after collecting $200m in series A funding, BGI gene sequencing spinoff MGI Tech has closed a $1bn series B round co-led by IDG Capital and CPE Capital.
May 28, 2020AbCellera accelerates with $105m
Eli Lilly invested in AbCellera's series B round shortly after agreeing a research and collaboration licensing deal with the drug discovery technology provider.
May 28, 2020Enview entertains Statkraft in $12m round
Statkraft Ventures contributed to a round for the 3D geospatial analysis platform developer that was led by BrightCap Ventures.
May 27, 2020Higi measures out $30m
Babylon Health led a series B round for the healthcare measurement kiosk provider that also featured Rush University Medical Center for Health.
May 27, 2020Insitro inserts $143m in series B round
WuXi AppTec's Corporate Venture Fund and GV participated in a round that came two years after the drug discovery system developer raised money at a unicorn valuation.
May 27, 2020Platform Science navigates $42m series B
The trucking management software provider secured $42m in a round led by Prologis Ventures that also featured new strategic partner Daimler.
May 27, 2020Daily deal net: May 26, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
May 26, 2020Truework verifies $30m
Truework, which provides software to run employment and income background checks, secured the return of Sequoia Capital and Khosla Ventures to bring its total to $45m.
May 26, 2020GSK hits HotSpot in $65m series B
The cancer, autoimmune and rare disease drug developer completed a $65m round that also featured MRL Ventures Fund and Cleva Pharma.
May 26, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


